Compounder Warned for Long List of GMP Violations

Drug Industry Daily
A A
A Texas-based compounder specializing in hormone therapies for men and women was warned by the FDA for extensive cGMP violations as well as producing drugs for which there was no valid prescription.

To View This Article:

Login

Subscribe To Drug Industry Daily